Skip to main content
MEDLEY,INC. logo

MEDLEY,INC. — Investor Relations & Filings

Ticker · 4480 ISIN · JP3921310003 LEI · 353800VX74BO9P8XHJ87 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 73 across all filing types
Latest filing 2024-11-20 M&A Activity
Country JP Japan
Listing T 4480

About MEDLEY,INC.

https://www.medley.jp/en/

MEDLEY, INC. is a healthcare technology company that develops and provides internet-based services to address challenges in the medical field. The company's operations are centered on two main business segments: a Human Resources (HR) Platform and a Medical Platform. The HR Platform business offers online recruitment services and career marketplaces, such as Jobley, designed to connect healthcare professionals with medical and caregiving institutions. The Medical Platform business provides technology solutions for patients and medical facilities, with its core product being CLINICS, a prominent telemedicine system that facilitates remote medical consultations. Through these platforms, Medley aims to realize more accessible and "reasonable medical care" by leveraging technology to improve efficiency and connectivity for patients, professionals, and institutions.

Recent filings

Filing Released Lang Actions
臨時報告書
M&A Activity Classification · 100% confidence The document is titled '臨時報告書' (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau Director. The filing reason explicitly states that the board resolved to transfer all shares of a specified subsidiary (株式会社メディパス) to a newly formed entity (株式会社メディパスホールディングス). This action results in the subsidiary ceasing to be a 'specified subsidiary' of the reporting company. This type of filing, which reports a significant change in corporate structure, ownership, or control, often falls under the category of a major corporate event disclosure. In the context of Japanese regulatory filings, an 'Extraordinary Report' (臨時報告書) is a general disclosure document used for significant events not covered by standard periodic reports (like 10-K or IR). Since the event is a divestiture/spin-off leading to a loss of subsidiary status, and it doesn't fit perfectly into CAP (Financing), TAR (M&A), or SHA (Share Issue), it is best classified as a general Regulatory Filing (RNS) or potentially a specific corporate action disclosure. Given the options, RNS (Regulatory Filings) is the most appropriate fallback for a specific, non-periodic, mandatory disclosure like this Extraordinary Report, especially since it details a change in corporate structure/ownership status.
2024-11-20 Japanese
臨時報告書
Regulatory Filings
2024-11-14 Japanese
臨時報告書
M&A Activity Classification · 100% confidence The document is titled with Japanese headers indicating it is a '臨時報告書' (Extraordinary Report) submitted to the '関東財務局長' (Kanto Local Finance Bureau Director) on September 30, 2024. The content explicitly states the reason for filing under the Financial Instruments and Exchange Act (金融商品取引法) and related regulations (企業内容等の開示に関する内閣府令第19条第2項第3号, 第8号の2) is due to the acquisition of all shares of another company ('株式会社オフショア') resulting in a change of a specified subsidiary ('特定子会社の異動'). This structure and content strongly align with a mandatory disclosure filing in Japan concerning a significant corporate action, specifically an acquisition/change of control. While the content details the acquisition (M&A activity), the primary regulatory filing type for this specific disclosure document in the Japanese context, which reports on significant events like subsidiary acquisition and change of control, is best categorized as a general Regulatory Filing (RNS) or potentially a specific M&A filing if available. Given the provided options, and recognizing this is a formal, mandatory disclosure document detailing a major corporate event (acquisition leading to a specified subsidiary change), it fits the scope of significant regulatory reporting. Since 'TAR' (M&A Activity) is defined as 'merger proposals or takeover bids,' and this is a definitive acquisition, 'TAR' is a strong candidate, but 'RNS' (Regulatory Filings) is the general catch-all for mandatory disclosures not perfectly matching other specific types. However, the core event is the acquisition of a subsidiary. In many contexts, a definitive acquisition report is classified under M&A. Given the detailed nature of the acquisition report, 'TAR' (M&A Activity) is the most specific fit for the substance, even though the Japanese form is an Extraordinary Report. Since the document details the acquisition price, target financials, and change in control, 'TAR' is chosen over the generic 'RNS'. The document length is substantial, ruling out RPA.
2024-09-30 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the company's interim report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like an interim report. H1 2024
2024-08-14 Japanese
半期報告書－第16期(2024/01/01－2024/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Medley, Inc. with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, management analysis (MD&A), and corporate information for the interim period from January 1, 2024, to June 30, 2024. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2024
2024-08-14 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, signed by the CEO and CFO of Medley, Inc. It explicitly states that the purpose is to confirm the accuracy of the contents of the Quarterly Report for the first quarter of the 16th fiscal year. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS) rather than the report itself. Q1 16
2024-05-14 Japanese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.